Frequent MAGE mutations in human melanoma

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-7

  Caballero, Otavia L ^a,i   Zhao, Qi ^b   Rimoldi, Donata ^c   Stevenson, Brian J ^c   Svobodová, Suzanne ^d   Devalle, Sylvie ^a   Róhrig, Ute F ^c   Pagotto, Anna ^e   Michielin, Olivier ^c   Speiser, Daniel ^c   Wolchok, Jedd D ^a   Liu, Cailian ^a   Pejovic, Tanja ^f   Odunsi, Kunle ^g   Brasseur, Francis ^h   van den Eynde, Benoit J ^h   Old, Lloyd J ^a   Lu, Xin ^e   Cebon, Jonathan ^d   Strausberg, Robert L ^d   Simpson, Andrew J ^d   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b J CRAIG VENTER INSTITUTE   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁱ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAGE GENE; MAGEA1 GENE; MAGEA4 GENE; MAGEC1 GENE; MAGEC2 GENE; MAGEE1 GENE; MAJOR CLINICAL STUDY; MELANOMA; MUTATIONAL ANALYSIS; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR GENE; X CHROMOSOME; ADULT; AGED; FEMALE; GENETICS; MALE; MIDDLE AGED; MUTATION; TUMOR CELL CULTURE;

MAGEA1 PROTEIN, HUMAN; MAGEA4 PROTEIN, HUMAN; MAGEC1 PROTEIN, HUMAN; MAGEC2 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 77958594600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012773     Document Type: Article

References (25)

1. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5: 615-625.
2. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, et al. (1994) Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 40: 360-369.
3. Caballero OL, Chen YT (2009) Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci 100: 2014-2021.
4. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, et al. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254: 1643-1647.
5. Brichard VG, Lejeune D (2008) Cancer immunotherapy targeting tumourspecific antigens: towards a new therapy for minimal residual disease. Expert Opin Biol Ther 8: 951-968.
6. Yang B, O'Herrin SM, Wu J, Reagan-Shaw S, Ma Y, et al. (2007) MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 67: 9954-9962.
7. Monte M, Simonatto M, Peche LY, Bublik DR, Gobessi S, et al. (2006) MAGEA tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A 103: 11160-11165.
8. Atanackovic D, Hildebrandt Y, Jadczak A, Cao Y, Luetkens T, et al. (2010) Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells. Haematologica 95: 785-793.
9. Liu W, Cheng S, Asa SL, Ezzat S (2008) The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res 68: 8104-8112.
10. Jeon CH, Shin IH, Park JB, Chae HD (2010) Prognostic Significance of MAGE in Peritoneal Washes in Gastric Carcinoma Patients Without Peritoneal Metastasis: Results of a 5-year Follow-up Study. J Clin Gastroenterol.
11. Gure AO, Chua R, Williamson B, Gonen M, Ferrera CA, et al. (2005) Cancertestis genes are coordinately expressed and are markers of poor outcome in nonsmall cell lung cancer. Clin Cancer Res 11: 8055-8062.
12. Atanackovic D, Luetkens T, Hildebrandt Y, Arfsten J, Bartels K, et al. (2009) Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma. Clin Cancer Res 15: 1343-1352.
13. Bergeron A, Picard V, LaRue H, Harel F, Hovington H, et al. (2009) High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer. Int J Cancer 125: 1365-1371.
14. Grau E, Oltra S, Martinez F, Orellana C, Canete A, et al. (2009) MAGE-A1 expression is associated with good prognosis in neuroblastoma tumors. J Cancer Res Clin Oncol 135: 523-531.
15. Sharma P, Shen Y, Wen S, Bajorin DF, Reuter VE, et al. (2006) Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. Clin Cancer Res 12: 5442-5447.
16. Peikert T, Specks U, Farver C, Erzurum SC, Comhair SA (2006) Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res 66: 4693-4700.
17. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
18. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
19. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
20. Pejovic T, Pande NT, Mori M, Mhawech-Fauceglia P, Harrington C, et al. (2009) Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol 2: 341-349.
21. Singer G, Stohr R, Cope L, Dehari R, Hartmann A, et al. (2005) Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol 29: 218-224.
22. COSMIC (Catalogue Of Somatic Mutations In Cancer) (accessed 2010) http://www.sanger.ac.uk/genetics/CGP/cosmic/.
23. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
24. Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, et al. (2003) MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 278: 10668-10674.
25. Guerois R, Nielsen JE, Serrano L (2002) Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 320: 369-387.